William Rosa, PhD, MBE, MS

William Rosa, PhD, MBE, MS

Behavioral Scientist

My Role at MSK

Areas of Expertise

My Specialties

  • Palliative and End-Of-Life Care
  • Health Equity
  • LGBTQ+ Inclusive Care
English
Share

About Me

What I Do at MSK
  • Assistant Attending Behavioral Scientist
My Role at MSK

A behavioral scientist has special training in studying human behavior.

Areas of Expertise

My Specialties

  • Palliative and End-Of-Life Care
  • Health Equity
  • LGBTQ+ Inclusive Care
Education & Honors

Education

  • PhD, University of Pennsylvania School of Nursing
  • Master of Bioethics (MBE), University of Pennsylvania Perelman School of Medicine
  • MS, The City University of New York at Hunter College

Awards and Honors

  • Current: Scientific Advisory Committee, Lancet Commission on Cancer and Health Systems
  • Current: Collaborator, Lancet Commission on Breast Cancer
  • Fellow in Palliative Care Nursing, Hospice & Palliative Nurses Association (2023)
  • HPNA New Investigator Award, Hospice & Palliative Nurses Association (to be awarded, 2023)
  • Visiting Research Scholar (honorary appointment)
  • University of Miami Institute for Advanced Study of the Americas and Hemispheric and Global Affairs (2022-2023)
  • Loretta C. Ford Award for Advancement of the Nurse Practitioner Role in Health Care Fellows of the American Association of Nurse Practitioners (2022)
  • Excellence in Oncology Nursing Health Policy and Advocacy Award
  • Oncology Nursing Society (2022)
  • IAHPC Individual Recognition Award (High-Income Country Category), International Association for Hospice & Palliative Care (2022)
  • Cambia Sojourns Scholar, Cambia Health Foundation Sojourns Scholars Leadership Development Program (2021-2023)
  • Crain’s Notable in Health Care 2021, Crain’s New York Business (2021)
  • APOS Health Equity Scholar, American Psychosocial Oncology Society (2021)
  • Research Dissertation Award, International Award for Nursing Excellence
  • Sigma Theta Tau International Honor Society of Nursing (2021)
  • Global Nursing Leadership Institute Scholar, International Council of Nurses (2020-2021)
  • Fellow, American Association of Nurse Practitioners (2019)
  • Fellow, American Academy of Nursing (2018)
  • Fellow, American College of Critical Care Medicine (2018-2021)
  • Robert Wood Johnson Foundation Future of Nursing Scholar (2017-2020)
  • Fellow, New York Academy of Medicine (2016)

Fellowships

  • Hospice & Palliative Medicine Fellowship, Memorial Sloan Kettering Cancer Center
  • Psychosocial, Palliative, and Community Research in Cancer, Memorial Sloan Kettering Cancer
  • Center/National Cancer Institute/National Institutes of Health

Board Certifications

  • Adult-Gerontological Primary Care Nurse Practitioner, American Nurses Credentialing Center

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA retirees only)

In Network Coverage Type
PPO

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

Blue Cross Blue Shield New York

In Network Coverage Type
PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

Blue Cross Health Plus

In Network Coverage Type
HMO

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

MSK has a tentative agreement with Cigna to continue coverage in 2024.

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage

In Network Coverage Type
PPO, HMO

Empire Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

Fidelis

In Network Coverage Type
HMO, EPO

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Comskil: Communication Skills Training Program & Research Laboratory doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View Dr. Rosa’s bibliography.

View Dr. Rosa’s Google Scholar citations.

Rosa WE, Lynch KA, Hadler RA, Mahoney C, Parker PA. “It Took Away and Stripped a Part of Myself”: Clinician Distress and Recommendations for Future Telepalliative Care Delivery in the Cancer Context. Am J Hosp Palliat Care. 2023 Feb;40(2):235-243. doi: 10.1177/10499091221101883. Epub 2022 May 15. PMID: 35574961; PMCID: PMC9663759.

Rosa WE, Izumi S, Sullivan DR, Lakin J, Rosenberg AR, Creutzfeldt CJ, Lafond D, Tjia J, Cotter V, Wallace C, Sloan DE, Cruz-Oliver DM, DeSanto-Madeya S, Bernacki R, Leblanc TW, Epstein AS. Advance Care Planning in Serious Illness: A Narrative Review. J Pain Symptom Manage. 2023 Jan;65(1):e63-e78. doi: 10.1016/j.jpainsymman.2022.08.012. Epub 2022 Aug 24. PMID: 36028176; PMCID: PMC9884468.

Read more

Rosa WE, Roberts KE, Braybrook D, Harding R, Godwin K, Mahoney C, Mathew S, Atkinson TM, Banerjee SC, Haviland K, Hughes TL, Walters CB, Parker PA. Palliative and end-of-life care needs, experiences, and preferences of LGBTQ+ individuals with serious illness: A systematic mixed-methods review. Palliat Med. 2022 Dec 7:2692163221124426. doi: 10.1177/02692163221124426. Epub ahead of print. PMID: 36475950.

Bao Y, Zhang H, Bruera E, Portenoy R, Rosa WE, Reid MC, Wen H. Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment. JAMA Oncol. 2022 Dec 1:e225623. doi: 10.1001/jamaoncol.2022.5623. Epub ahead of print. PMID: 36454553; PMCID: PMC9716439.

Rosa WE, Chittams J, Riegel B, Ulrich CM, Meghani SH. Patient Trade-Offs Related to Analgesic Use for Cancer Pain: A MaxDiff Analysis Study. Pain Manag Nurs. 2020 Jun;21(3):245-254. doi: 10.1016/j.pmn.2019.07.013. Epub 2019 Oct 21. PMID: 31648906; PMCID: PMC7170763.

 

Publications on PubMed

Visit PubMed for a full listing of Dr. Rosa’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

William Rosa discloses the following relationships and financial interests:

  • Jones & Bartlett Learning
    Intellectual Property Rights
  • Journal of Pain and Symptom Management
    Professional Services and Activities
  • Springer Publisher
    Intellectual Property Rights
  • University of Miami
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures